Dechert Advises on Sale of Alameda Healthcare Group’s Assets in the Middle East and North Africa Region to Cleopatra Hospital Group
December 25, 2020
Dechert LLP has advised Alameda Healthcare Group, one of the leading healthcare service providers in the Middle East and North Africa (MENA) region, on its definitive agreement to sell 100% of Alameda Healthcare Group’s assets in Egypt to Cleopatra Hospital Group S.A.E.(CHG). CHG is Egypt’s largest private hospital group by number of hospital beds and number of operating hospitals and is listed on the Egyptian Stock Exchange. The transaction is conditional on Egyptian Competition Authority and Ministry of Health approvals in addition to detailed confirmatory due-diligence and shareholder and regulatory approvals. The deal is expected to complete during the first half of 2021.
The transaction is one of the most significant healthcare transactions in the region in the last few years, and Dechert’s representation of Alameda Group continues to cement Dechert’s expertise and experience as a leader in the healthcare and life sciences sector in the Middle East and North Africa region.
The Dechert team advising Dr. Fahad Khater was led by Dubai-based corporate partner Philip Dowsett, and included Chris Sioufi, Chris Field, Eduardo Silva Romero, Katrina Morrison and Jago Chanter.
About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
